Subinhibitory quinupristin/dalfopristin attenuates virulence of Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 58, Issue 3, 2006, Pages 564-574

  Koszczol, Carmen ^a   Bernardo, Katussevani ^a   Krönke, Martin ^a   Krut, Oleg ^a,b  

^a UNIVERSITY OF COLOGNE   (Germany)

^b BIOCRATES LIFE SCIENCES AG   (Austria)

Author keywords

Antibiotics; Exoproteins; Mass spectrometry; Proteomics

Indexed keywords

AUTOLYSIN; BACTERIAL PROTEIN; CLINDAMYCIN; DALFOPRISTIN PLUS QUINUPRISTIN; EXOPROTEIN; HEMOLYSIN; LINEZOLID; PROTEIN A; STAPHYLOCOCCUS TOXIN; TRIACYLGLYCEROL LIPASE; TUMOR NECROSIS FACTOR; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERICIDAL ACTIVITY; BACTERIUM CULTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; MACROPHAGE; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; MINIMUM INHIBITORY CONCENTRATION; MOUSE; NONHUMAN; POLYACRYLAMIDE GEL ELECTROPHORESIS; PROTEIN SECRETION; PROTEIN SYNTHESIS INHIBITION; STAPHYLOCOCCUS AUREUS; TWO DIMENSIONAL GEL ELECTROPHORESIS; WESTERN BLOTTING;

ANIMALS; ANTI-BACTERIAL AGENTS; CELL LINE; DOSE-RESPONSE RELATIONSHIP, DRUG; ELECTROPHORESIS, POLYACRYLAMIDE GEL; EXOTOXINS; FIBROBLASTS; MICE; MICROBIAL SENSITIVITY TESTS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; STAPHYLOCOCCUS AUREUS; VIRGINIAMYCIN; VIRULENCE; VIRULENCE FACTORS;

EID: 33747893348     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkl291     Document Type: Article

References (26)

1. Lowy FD. Staphylococcus aureus infections. N Engl J Med 1998; 339: 520-32.
2. Zetola N, Francis JS, Nuermberger EL et al. Community-acquired meticillin-resistant Staphylococcus aureus: An emerging threat. Lancet Infect Dis 2005; 5: 275-86.
3. Ohlsen K, Ziebuhr W, Koller KP et al. Effects of subinhibitory concentrations of antibiotics on alpha-toxin (hla) gene expression of methicillin-sensitive and methicillin-resistant Staphylococcus aureus isolates. Antimicrob Agents Chemother 1998; 42: 2817-23.
4. Shibl AM. Effect of antibiotics on production of enzymes and toxins by microorganisms. Rev Infect Dis 1983; 5: 865-75.
5. Hallander HO, Laurell G, Lofstrom G. Enhancement of staphylococcal pathogenicity in the presence of penicillin. Acta Pathol Microbiol Scand 1966; 68: 463-4.
6. Schlievert PM, Kelly JA. Clindamycin-induced suppression of toxic-shock syndrome - associated exotoxin production. J Infect Dis 1984; 149: 471.
7. Bernardo K, Pakulat N, Fleer S et al. Subinhibitory concentrations of linezolid reduce Staphylococcus aureus virulence factor expression. Antimicrob Agents Chemother 2004; 48: 546-55.
8. Gemmell CG, Shibl AM. The control of toxin and enzyme biosynthesis in staphylococci by antibiotics. In: Jeljaszewicz J, ed. International Symposium on Staphylococci and Staphylococcal Infections. 3rd edn. Stuttgart, Germany: Gustav Fischer, 1976; 657-64.
9. Veringa EM, Verhoef J. Influence of subinhibitory concentrations of clindamycin on opsonophagocytosis of Staphylococcus aureus, a protein-A-dependent process. Antimicrob Agents Chemother 1986; 30: 796-7.
10. Eliopoulos GM. Quinupristin-dalfopristin and linezolid: Evidence and opinion. Clin Infect Dis 2003; 36: 473-81.
11. Chant C, Rybak MJ. Quinupristin/dalfopristin (RP 59500): A new streptogramin antibiotic. Ann Pharmacother 1995; 29: 1022-7.
12. Cocito C, Di Giambattista M, Nyssen E et al. Inhibition of protein synthesis by streptogramins and related antibiotics. J Antimicrob Chemother 1997; 39 Suppl A: 7-13.
13. Yarwood JM, Schlievert PM. Quorum sensing in Staphylococcus infections. J Clin Invest 2003; 112: 1620-5.
14. Novick RP. Autoinduction and signal transduction in the regulation of staphylococcal virulence. Mol Microbiol 2003; 48: 1429-49.
15. Cheung AL, Zhang G. Global regulation of virulence determinants in Staphylococcus aureus by the SarA protein family. Front Biosci 2002; 7: d1825-42.
16. Shevchenko A, Wilm M, Vorm O et al. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal Chem 1996; 68: 850-8.
17. O'Farrell PH. High resolution two-dimensional electrophoresis of proteins. J Biol Chem 1975; 250: 4007-21.
18. Görg A, Postel W, Gunther S. The current state of two-dimensional electrophoresis with immobilized pH gradients. Electrophoresis 1988; 9: 531-46.
19. Bernardo K, Fleer S, Pakulat N et al. Identification of Staphylococcus aureus exotoxins by combined sodium dodecyl sulfate gel electrophoresis and matrix-assisted laser desorption/ionization-time of flight mass spectrometry. Proteomics 2002; 2: 740-6.
20. Mattsson E, Van Dijk H, Verhoef J et al. Supernatants from Staphylococcus epidermidis grown in the presence of different antibiotics induce differential release of tumor necrosis factor alpha from human monocytes. Infect Immun 1996; 64: 4351-5.
21. Lowy FD. Is Staphylococcus aureus an intracellular pathogen? Trends Microbiol 2000; 8: 341-3.
22. Krut O, Utermöhlen O, Schlossherr X et al. Strain-specific association of cytotoxic activity and virulence of clinical Staphylococcus aureus isolates. Infect Immun 2003; 71: 2716-23.
23. Blickwede M, Wolz C, Valentin-Weigand P et al. Influence of clindamycin on the stability of coa and fnbB transcripts and adherence properties of Staphylococcus aures Newman. FEMS Microbiol Lett 2005; 252: 73-8.
24. Gemmell CG. Antibiotics and expression of microbial virulence factors: implications for host defense. J Chemother 1991; 3 Suppl 1: 105-11.
25. Herbert S, Barry P, Novick RP. Subinhibitory clindamycin differentially inhibits transcription of exoprotein genes in Staphylococcus aureus. Infect Immun 2001; 69: 2996-3003.
26. Bisognano C, Vaudaux PE, Lew DP et al. Increased expression of fibronectin-binding proteins by fluoroquinolone-resistant Staphylococcus aureus exposed to subinhibitory levels of ciprofloxacin. Antimicrob Agents Chemother 1997; 41: 906-13.